Table 2. Association between YAP1 and cancer patients’ prognosis in GEPIA.

Tumor type	No of YAP1 expression		OS			DFS
	High	Low	p	HR(high)	p(HR)	p	HR(high)	p(HR)
Total tumor	4746	4746	0.00007	1.2	0.000072	0.21	1	0.21
Liver cancer	199	199	0.2	1.2	0.2	0.67	1.1	0.67
Lung cancer	481	481	0.39	1.1	0.39	0.67	1.1	0.67
Esophageal carcinoma	91	91	0.012	0.56	0.013	0.96	1	0.95
Stomach adenocarcinoma	192	192	0.92	0.98	0.92	0.35	0.83	0.34
Colorectal cancer	181	180	0.095	0.69	0.096	0.79	1.1	0.79
Bladder Urothelial Carcinoma	201	201	0.14	1.2	0.14	0.036	1.4	0.037
Renal cancer	432	432	0.69	0.95	0.69	0.94	0.99	0.94
Breast invasive carcinoma	534	535	0.17	1.3	0.17	0.48	0.88	0.49
Uterine cancer	261	261	0.31	1.2	0.3	0.92	0.66	0.65
Ovarian serous cystadenocarcinoma	212	212	0.56	1.1	0.56	0.62	1.1	0.61
Glioma	338	338	0.000002	1.8	0.0000027	0.00016	1.6	0.00018
Others	1624	1624	0.0012	1.3	0.0012	0.069	1.1	0.069

Abbreviations: DFS disease-free survival; HR hazard ratio; OS overall survival.